Skip to content

NUTRIPHARM

Inactive
KBO/BCE: BE 0472.551.237

NUTRIPHARM was declared bankrupt on 29-01-2020 (Tribunal de l’entreprise de Liège, division Liège); the bankruptcy was closed by liquidation by judgment of 18-10-2022, published in the Belgian Official Gazette on 24-10-2022.

Summary

Inactive; last annual accounts for financial year 2018.

Follow Report
NUTRIPHARMInactive
Report

Financials · financial year 2018, full format

2018 annual accounts filed late (30 days) Filed on 30 August 2019, deadline 31 July 2019 (7 months after the close on 31 December 2018, Companies Code art. 3:10). Source: NBB, 2019-61800534.

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€49,538
Working capital
€40,259
Balance-sheet composition
Assets €613,677
Fixed assets €202,409
Current assets €411,268
Equity and liabilities €613,677
Equity €238,623
Debt €375,054
Debt finances 61.1% of the balance-sheet total.
Key figures and ratios
2018 value
EBITDA
€31,949
Cash flow
€14,483
Current ratio
1.11
Quick ratio
0.72
ROE
-20.8%
ROA
-8.1%
Debt ≤ 1 year
€371,009
Income taxes
€1,168
Annual accounts
Filed annual accounts As filed with the NBB · 2018 · 26 lines
Balance sheet Code2018
Assets
Total assets20/58€613,677
Fixed assets21/28€202,409
Intangible fixed assets21€77,034
Tangible fixed assets22/27€97,851
Financial fixed assets28€27,523
Current assets29/58€411,268
Stocks and contracts in progress3€145,810
Amounts receivable within one year40/41€231,140
Cash at bank and in hand54/58€33,906
Equity and liabilities
Total equity and liabilities10/49€613,677
Equity10/15€238,623
Contributions10/11€191,068
Reserves13€1,958
Profit (loss) carried forward14€45,596
Amounts payable17/49€375,054
Amounts payable within one year42/48€371,009
Trade debts44€148,890
Income statement Code2018
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€64,020
Gross operating margin9900€371,058
Operating profit (loss)9901-€32,071
Recurring financial income75€2,801
Recurring financial charges65€19,100
Profit (loss) for the period before taxes9903-€48,370
Income taxes67/77€1,168
Profit (loss) for the period9904-€49,538
Profit (loss) for the period to be appropriated9905-€49,538
Line2018
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€64,020
Gross operating margin9900€371,058
Operating profit (loss)9901-€32,071
Recurring financial income75€2,801
Recurring financial charges65€19,100
Profit (loss) for the period before taxes9903-€48,370
Income taxes67/77€1,168
Profit (loss) for the period9904-€49,538
Profit (loss) for the period to be appropriated9905-€49,538
Line2018
Assets
Total assets20/58€613,677
Fixed assets21/28€202,409
Intangible fixed assets21€77,034
Tangible fixed assets22/27€97,851
Financial fixed assets28€27,523
Current assets29/58€411,268
Stocks and contracts in progress3€145,810
Amounts receivable within one year40/41€231,140
Cash at bank and in hand54/58€33,906
Equity and liabilities
Total equity and liabilities10/49€613,677
Equity10/15€238,623
Contributions10/11€191,068
Reserves13€1,958
Profit (loss) carried forward14€45,596
Amounts payable17/49€375,054
Amounts payable within one year42/48€371,009
Trade debts44€148,890
Line2018
Profit (loss) for the period9904-€49,538
+ Depreciation and write-downs630€64,020
Operating cash flow (approximation)€14,483

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

We would like to set cookies. That happens only with your consent. What we measure